Tratamiento del carcinoma basocelular periocular con una combinación sinérgica de interferones alpha-2b y gamma

@article{NegrnCceres2019TratamientoDC,
  title={Tratamiento del carcinoma basocelular periocular con una combinaci{\'o}n sin{\'e}rgica de interferones alpha-2b y gamma},
  author={Yairan Negr{\'i}n-C{\'a}ceres and Ailyn del Carmen Cabrera-Romero and Ledisleydy C{\'a}rdenas-Monz{\'o}n and Arletis Ferrer-P{\'e}rez and Norma E. Batista-Hern{\'a}ndez},
  journal={Revista Mexicana de Oftalmolog{\'i}a},
  year={2019}
}
Purpose: To evaluate the results for the application of the perilesional HerberPAG on periocular basal cell carcinoma. Methods: An experimental investigation was carried out on a group of 7 patients who were given the same treatment regimen with HeberPAG® 10.5 × 106 UI 3 times a week for 3 consecutive weeks. Demographic variables where considered as well as time of evolution, initial injury size, clinical subtype, histological subtype, clinical response, objective response and adverse effects… 
Uso del HeberFERON® en un paciente VIH/sida con carcinoma basocelular
TLDR
Con el uso del HeberFERON® se logro en este paciente la regresion completa del carcinoma basocelular facial that padecia, and se evito la realizacion of un acto quirurgico no consentido.

References

SHOWING 1-10 OF 40 REFERENCES
Oculoplastic aspects of ocular oncology
TLDR
The purpose of this article is to review the management of malignant periocular tumours, with particular emphasis on surgical management.
Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids
TLDR
Imiquimod cream (5%) provides an effective alternative therapy for the treatment of nodular BCC of the eyelid, although surgical treatment remains the gold standard at the present time.
Uso de HeberPAG en carcinoma basocelular periocular
TLDR
El caso clinico de un paciente de 34 anos de edad con un carcinoma basocelular nodular de parpado inferior del ojo izquierdo, y el potencial destructor de this tumor, asi como las tecnicas utilizadas en el manejo de esta patologia.
Mohs' micrographic surgery for treatment of basal cell carcinoma of the face——results of a retrospective study and review of the literature
Background   The incidence of skin cancer and especially basal cell carcinoma (BCC) has increased in the last decade and is still increasing. Many treatment modalities can be used to treat BCC;
Clinicopathological analysis of eyelid malignancies - A review of 85 cases
TLDR
It is recommended that the surgeons treating eyelid malignancies in India should have a high index of suspicion for SGC, as these tumours in the Indian population have considerable variations in case distribution and presentation.
Retrospective Study of Periocular Non Melanoma Skin Cancer Treated with the Combination of IFN alpha2b and Gamma (HeberPAG)
TLDR
Evaluated retrospectively, HeberPAG is an alternative useful to surgery in patients with periocular non-melanoma skin cancer when other therapies have failed or are not possible and justifies further confirmatory trials inPeriocular region.
Advances in the management of basal cell carcinoma
TLDR
Targeted molecular therapeutic options for the treatment of advanced or metastatic BCC will be discussed in this informal review based on recent literature obtained by using PubMed with relevant search terms.
Clinicopathologic features and prognostic factors of malignant eyelid tumors.
TLDR
Clinicians should have a high level of suspicion for recurrence according to histological type when treating patients with eyelid tumor and it is important to achieve a negative tumor margin in canthus located malignant eyelid tumors.
Treatment of Facial Basal Cell Carcinoma: A Review
TLDR
Although traditionally standard excision has been the treatment of choice various other options are available including: Mohs micrographic surgery, curettage and cautery, cryosurgery, radiotherapy, topical imiquimod, photodynamic therapy and topical 5-fluorouracil.
...
...